TBPH
Theravance Biopharma Inc
17.00$
+0.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
Theravance Biopharma Inc (TBPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -8.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.5 | -0.9 | -1.0 | -4.4 | -5.2 | -0.9 | 43 | 208 | -6.5 | -6.1 | 73 | -8.9 | 52 | |
| 0.9 | 1.4 | 1.2 | 1.0 | 0.8 | 0.7 | 1.1 | 0.9 | 0.6 | 0.4 | 0.8 | 2.0 | 3.9 | |
| 6.3 | 5.8 | 5.2 | 5.4 | 5.0 | 5.8 | 4.9 | 4.5 | 4.6 | 4.5 | 4.5 | 6.0 | 20 | |
| -1.3 | -3.4 | 4.1 | 2.7 | -0.3 | 14 | 52 | 158 | -17 | 262 | 76 | -78 | 243 | |
| 0.0 | 0.7 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | -0.7 | 17 | -3.0 | -17 | 16 | 31 | -36 | -100 | 0.6 | 53 | -60 | -107 | |
| -31 | -31 | -1.7 | -0.5 | -0.4 | -0.5 | -0.9 | -0.5 | -0.7 | -2.0 | -5.8 | 5.8 | -2.7 | |
| -31 | -31 | -1.7 | 0.0 | -0.4 | -0.4 | -0.9 | -0.5 | -0.4 | -1.5 | -5.6 | 4.6 | -2.9 | |
| -34 | -32 | 14 | -7.5 | -23 | 14 | 73 | 171 | -107 | -7.0 | 120 | -65 | -59 | |
| -2.5 | -1.5 | -1.1 | -4.5 | -5.2 | -1.1 | 43 | 208 | -6.5 | -6.1 | 73 | -8.9 | 52 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.